Ustekinumab for the Prevention of Acute Graft-versus-Host Disease After Unrelated Donor Hematopoietic Cell Transplant

Clinical trial NCT04572815 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04572815
Sponsor: Fred Hutchinson Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hematologic and Lymphocytic Disorder Hematopoietic and Lymphoid System Neoplasm

Start date: 2021-05-14
Primary completion: 2025-10-27
Enrollment: 116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.